Melanotan II vs PTD-DBM

Melanotan II: Synthetic melanocortin peptide with tanning, appetite-suppressive, and sexual function effects. Typical dose 250-1000 mcg. PTD-DBM: Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent. Typical dose Topical formulation-dependent mcg. Both fall under the Cosmetic category.

Stacking Melanotan II with PTD-DBM is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Melanotan II is typically dosed: Once daily for Tanning (loading phase); Once or twice weekly for Tanning (maintenance); As needed, 1-2 hours before activity for Sexual function enhancement. PTD-DBM is typically dosed: Daily topical application to scalp for Topical hair regrowth research.

Melanotan II: Not FDA approved. The FDA has issued warnings against the use of Melanotan II, citing it as an unregulated and potentially dangerous product. The derivative PT-141 (bremelanotide/Vyleesi) was approved for sexual dysfunction but Melanotan II itself was not pursued for approval. PTD-DBM: Not FDA approved.